Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 9OTHER 5OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5Sarcoma 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5Sarcoma, Myeloid 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × vosaroxin × Clear all
NCT02658487 2025-04-15

VITAL

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
42 enrolled 12 charts
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

NCT01893320 2022-02-09

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

M.D. Anderson Cancer Center

Phase 1/2 Completed
66 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03338348 2020-10-28

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

University of Ulm

Phase 2 Completed
9 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02272478 2020-01-23

AML18

Cardiff University

Phase 2/3 Unknown
1,600 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02485353 2017-09-20

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Indiana University

Phase NA Terminated
2 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡